참고문헌
- Anand S, Hanson K (1997). Disability-adjusted life years: a critical review. J Health Econ, 16, 685-702. https://doi.org/10.1016/S0167-6296(97)00005-2
- Barker C, Green A (1996). Opening the debate on DALYs (disability-adjusted life years). Health policy plann, 11, 179-83. https://doi.org/10.1093/heapol/11.2.179
- Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
- Bray F, MAller B (2006). Predicting the future burden of cancer. Nat Rev Cancer, 6, 63-74. https://doi.org/10.1038/nrc1781
- Bray F, Ren JS, Masuyer E, Ferlay J (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132, 1133-45. https://doi.org/10.1002/ijc.27711
- Cho KH, Park S, Lee KS, et al (2013). A single measure of cancer burden in Korea from 1999 to 2010. Asian Pac J Cancer Prev, 14, 5249-55 https://doi.org/10.7314/APJCP.2013.14.9.5249
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Gold MR, Stevenson D, Fryback DG. (2002). HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. Annu Rev Pub Health, 23, 115-34. https://doi.org/10.1146/annurev.publhealth.23.100901.140513
- Hakama M, Hakulinen T, Teppo L, Saxen E (1975). Incidence, mortality or prevalence as indicators of the cancer problem. CA-Cancer J Clin, 36, 2227-31.
- Health people 2010 Toolkit. A field guide to health planning. (2002). Public Health Foundation, 67-9.
- Ismail SI, Soubani M, Nimri JM, Al-Zeer AH (2013). Cancer incidence in Jordan from 1996 to 2009-A comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34. https://doi.org/10.7314/APJCP.2013.14.6.3527
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA-Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA-Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
- Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. https://doi.org/10.1200/JCO.2005.05.2308
- Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20. https://doi.org/10.7314/APJCP.2012.13.2.411
- McCracken M, Olsen M, Chen MS, et al (2007). Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin, 57, 190-205. https://doi.org/10.3322/canjclin.57.4.190
- Mont D (2007). Measuring health and disability. Lancet, 369, 1658-63. https://doi.org/10.1016/S0140-6736(07)60752-1
- Neevan DR, Dsouza, NS Murthy, RY Aras (2013). Projection of cancer incident cases for India-till 2026. Asian Pac J Cancer Prev, 14, 4379-86. https://doi.org/10.7314/APJCP.2013.14.7.4379
- Ollberding NJ, Nomura AM, Wilkens LR, et al (2011). Racial/ ethnic differences in colorectal cancer risk: The multiethnic cohort study. Int J Cancer, 129, 1899-906. https://doi.org/10.1002/ijc.25822
- Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. https://doi.org/10.1016/S1470-2045(01)00486-7
- Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12 Suppl 1, S70-80. https://doi.org/10.1111/j.1075-122X.2006.00205.x
- Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Sant M, Francisci S, Capocaccia R, et al (2006). Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer, 119, 2417-22. https://doi.org/10.1002/ijc.22160
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al (2012). Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 24, 1840-50.
- Thun MJ, DeLancey JO, Center MM, et al (2010). The global burden of cancer: priorities for prevention. Carcinogenesis, 31, 100-10. https://doi.org/10.1093/carcin/bgp263
- Vainio H (2002). Social responsibility in cancer prevention research: IARC as a 'Global Science Force'. Asian Pac J Cancer Prev, 3, 267-72.
- Woolf SH, Stange KC (2006). A sense of priorities for the healthcare commons. Am J Prev Med, 31, 99-102.
- WHO (2002). Bull WHO, 80, 644-52.
- WHO. International Agency for Research on Cancer (IARC). http://globocan.iarc.fr/.
- WHO (2001). National burden of disease studies: a practical guide. 2nd ed. (2001). 9-15.
- WHO (2004). The Global Burden of Disease: 2004 update. (2008).
피인용 문헌
- Randomized Control Study of Nedaplatin or Cisplatin Concomitant with Other Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.731
- In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1767
- Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2685
- RETRACTED ARTICLE: Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients vol.10, pp.1, 2015, https://doi.org/10.1186/s13000-015-0391-0
- Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate vol.10, pp.8, 2015, https://doi.org/10.1371/journal.pone.0135704
- Description of Deaths on Easter Island, 2000-2012 Period vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10091
- Expression of Tumor Necrosis Factor Receptor-associated Factor 6 in Lung Cancer Tissues vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10591
- Years of Potential Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Iran vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1845
- vol.9, pp.1179-5549, 2015, https://doi.org/10.4137/CMO.S22456
- WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0160414
- Influence of Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the Incidence of Breast Cancer - a Case-Control Study in Jordan vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.261
- Ranking composite Cancer Burden Indices for geographic regions: point and interval estimates vol.29, pp.2, 2018, https://doi.org/10.1007/s10552-018-1000-9